Published in Arch Intern Med on December 01, 1974
Myelotoxicity of gold. Br Med J (1976) 1.58
The role of hypersensitivity and the immune response in influencing susceptibility to metal toxicity. Environ Health Perspect (1978) 0.75
Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest (1973) 31.28
Synthesis of antihemophilic factor antigen by cultured human endothelial cells. J Clin Invest (1973) 10.18
A human 88-kD membrane glycoprotein (CD36) functions in vitro as a receptor for a cytoadherence ligand on Plasmodium falciparum-infected erythrocytes. J Clin Invest (1989) 3.71
Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. Proc Natl Acad Sci U S A (1997) 3.30
Isolation of the thrombospondin membrane receptor. J Clin Invest (1987) 2.87
Synthesis of von Willebrand factor by cultured human endothelial cells. Proc Natl Acad Sci U S A (1974) 2.83
A clinical study of the lupus anticoagulant. Blood (1976) 2.81
Contractile proteins of endothelial cells, platelets and smooth muscle. Am J Pathol (1973) 2.36
Complex formation of platelet thrombospondin with fibrinogen. J Clin Invest (1982) 2.05
Complex formation of platelet membrane glycoproteins IIb and IIIa with fibrinogen. J Clin Invest (1982) 2.04
Treatment of refractory immune thrombocytopenic purpura with an anti-Fc gamma-receptor antibody. N Engl J Med (1986) 2.01
Thrombospondin is the endogenous lectin of human platelets. Nature (1982) 1.98
Increased vascular permeability produced by human platelet granule cationic extract. J Clin Invest (1970) 1.98
Characterization of hematopoietic cells arising on the textured surface of left ventricular assist devices. Ann Thorac Surg (1995) 1.96
Human bone marrow microvascular endothelial cells support long-term proliferation and differentiation of myeloid and megakaryocytic progenitors. Blood (1995) 1.94
Isolation and characterization of human bone marrow microvascular endothelial cells: hematopoietic progenitor cell adhesion. Blood (1994) 1.90
Binding of plasminogen to cultured human endothelial cells. J Biol Chem (1986) 1.87
Lipoprotein(a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis. Nature (1989) 1.85
Cancer and clotting--Trousseau's warning. N Engl J Med (1992) 1.78
Blockade of clearance of immune complexes by an anti-Fc gamma receptor monoclonal antibody. J Exp Med (1986) 1.75
Iodination of the human platelet membrane. Studies of the major surface glycoprotein. J Biol Chem (1973) 1.72
Interleukin 1 induces endothelial cell synthesis of plasminogen activator inhibitor. J Exp Med (1986) 1.68
Rabbit platelet bactericidal protein. J Exp Med (1971) 1.63
Subunit structure of factor VIII antigen synthesized by cultured human endothelial cells. J Clin Invest (1975) 1.56
Thrombospondin binds to monocytes-macrophages and mediates platelet-monocyte adhesion. J Clin Invest (1987) 1.53
Drug purpura. Semin Hematol (1965) 1.53
Complex formation of platelet thrombospondin with plasminogen. Modulation of activation by tissue activator. J Clin Invest (1984) 1.52
Tumor necrosis factor-mediated release of platelet-derived growth factor from cultured endothelial cells. J Exp Med (1987) 1.50
Subcellular platelet factor VIII antigen and von Willebrand factor. J Exp Med (1975) 1.43
Complex formation of platelet thrombospondin with histidine-rich glycoprotein. J Clin Invest (1984) 1.43
Transendothelial migration of megakaryocytes in response to stromal cell-derived factor 1 (SDF-1) enhances platelet formation. J Exp Med (1998) 1.43
Lipoid proteinosis: case report and review of the literature. Acta Otorhinolaryngol Ital (2006) 1.42
Cell-mediated immunity in rheumatic diseases. II. Mitogen responses in RA, SLE, and other illnesses: correlation with T- and B-lymphocyte populations. Arthritis Rheum (1975) 1.39
Binding of plasminogen to extracellular matrix. J Biol Chem (1986) 1.38
Isolation, purification, and partial characterization of platelet membrane glycoproteins IIb and IIIa. J Biol Chem (1981) 1.37
Lipoprotein (a) regulates plasminogen activator inhibitor-1 expression in endothelial cells. A potential mechanism in thrombogenesis. J Biol Chem (1991) 1.36
Thrombospondin sequence motif (CSVTCG) is responsible for CD36 binding. Biochem Biophys Res Commun (1992) 1.32
Glycoprotein IV mediates thrombospondin-dependent platelet-monocyte and platelet-U937 cell adhesion. J Clin Invest (1989) 1.32
Macrophage plasma membranes. I. Isolation and studies on protein components. J Exp Med (1971) 1.32
Human megakaryocytes. I. Characterization of the membrane and cytoplasmic components of isolated marrow megakaryocytes. J Exp Med (1979) 1.31
Human brain glial cells synthesize thrombospondin. Proc Natl Acad Sci U S A (1986) 1.29
Human megakaryocyte stimulation of proliferation of bone marrow fibroblasts. Blood (1981) 1.28
Plasminogen activator inhibitor is associated with the extracellular matrix of cultured bovine smooth muscle cells. J Clin Invest (1987) 1.28
Immunoinhibition of ristocetin-induced platelet aggregation. J Clin Invest (1977) 1.26
Platelet thrombospondin forms a trimolecular complex with plasminogen and histidine-rich glycoprotein. J Clin Invest (1985) 1.24
Human platelet activation by C3a and C3a des-arg. J Exp Med (1983) 1.22
Immunologic studies of proteins associated with subcellular fractions of normal human platelets. J Lab Clin Med (1967) 1.20
Characterization of human platelet vascular permeability-enhancing activity. J Clin Invest (1972) 1.20
Thrombospondin: a versatile multifunctional glycoprotein. Arteriosclerosis (1986) 1.19
Increased skin permeability in preterm infants. J Pediatr (1971) 1.18
Structural analysis of human platelet membrane glycoprotein I complex. Proc Natl Acad Sci U S A (1979) 1.18
Studies on human platelet protease activity. J Clin Invest (1969) 1.17
Binding of tissue plasminogen activator to cultured human endothelial cells. J Clin Invest (1987) 1.15
Immune complexes in uveitis. Am J Ophthalmol (1979) 1.14
Human megakaryocytes. II. Expression of platelet proteins in early marrow megakaryocytes. J Exp Med (1981) 1.14
Thrombin-induced platelet membrane glycoprotein IIb and IIIa complex formation. An electron microscope study. J Exp Med (1981) 1.13
Human complement in thrombin-mediated platelet function: uptake of the C5b-9 complex. J Exp Med (1979) 1.13
Activation of immobilized plasminogen by tissue activator. Multimolecular complex formation. J Biol Chem (1985) 1.12
Cellular attachment to thrombospondin. Cooperative interactions between receptor systems. J Biol Chem (1991) 1.12
Identification of a CD36-related thrombospondin 1-binding domain in HIV-1 envelope glycoprotein gp120: relationship to HIV-1-specific inhibitory factors in human saliva. J Exp Med (1998) 1.11
Multicenter study of immunoscintigraphy with radiolabeled monoclonal antibodies in patients with melanoma. Cancer Res (1986) 1.08
Macrophage plasma membrane. II. Studies on synthesis and turnover of protein constituents. J Exp Med (1971) 1.08
Histidine-rich glycoprotein inhibits the antiangiogenic effect of thrombospondin-1. J Clin Invest (2001) 1.08
Thrombocytopenia due to digitoxin. Demonstration of antibody and mechanisms of action. Am J Med (1966) 1.08
Transendothelial migration of CD34+ and mature hematopoietic cells: an in vitro study using a human bone marrow endothelial cell line. Blood (1997) 1.07
Studies on the proteins of human platelet membranes. J Biol Chem (1972) 1.06
Ultrastructure of thrombosthenin, the contractile protein of human blood platelets. Science (1967) 1.05
Human platelet membrane protein. Biochemistry (1970) 1.05
Studies on the mode of action of immunosuppressive ribonucleases. Antibiot Chemother (1969) 1.05
Ultrastructural lesions on the surface of platelets associated with either blood coagulation or with antibody-mediated immune injury. J Exp Med (1975) 1.04
The platelet as an inflammatory cell. Ann N Y Acad Sci (1972) 1.04
Histidine-rich glycoprotein is present in human platelets and is released following thrombin stimulation. Blood (1983) 1.04
Platelet membrane topography: colocalization of thrombospondin and fibrinogen with the glycoprotein IIb-IIIa complex. Blood (1985) 1.03
Interaction of platelet membrane receptors with von Willebrand factor, ristocetin, and the Fc region of immunoglobulin G. J Clin Invest (1978) 1.03
Binding of adenosine diphosphate by isolated membranes from human platelets. J Biol Chem (1974) 1.01
Matrix plasminogen activator inhibitor. Modulation of the extracellular proteolytic environment. J Biol Chem (1988) 1.00
Effector cell protease receptor-1 is a vascular receptor for coagulation factor Xa. J Biol Chem (1996) 0.99
Thrombospondin: phenomenology to function. Prog Hemost Thromb (1989) 0.99
Multiculturalism, Medicine and Health: Part VI. Can Fam Physician (1989) 0.99
BMEC-1: a human bone marrow microvascular endothelial cell line with primary cell characteristics. Microvasc Res (1996) 0.98
Structural analysis of factor VIII antigen in von Willebrand disease. Proc Natl Acad Sci U S A (1980) 0.98
Human complement in the arachidonic acid transformation pathway in platelets. J Exp Med (1981) 0.97
Reed-Sternberg cells in Hodgkin's disease contain fibronectin. Blood (1981) 0.96
Communication: Cross-cultural applications of the physician's art. Can Fam Physician (1992) 0.94
Multiculturalism, Medicine, and Health Part IV: Individual Considerations. Can Fam Physician (1989) 0.94
Inhibition of fibrin monomer polymerization by lambda myeloma globulins. Blood (1972) 0.93
Cytokine-enhanced expression of glycoprotein Ib alpha in human endothelium. J Biol Chem (1990) 0.92
Tissue plasminogen activator and urokinase enhance the binding of plasminogen to thrombospondin. J Biol Chem (1986) 0.92
Multiple molecular forms of endothelial cell factor VIII related antigen. Biochim Biophys Acta (1981) 0.91
Small mammals of Chapada dos Veadeiros National Park (Cerrado of Central Brazil): ecologic, karyologic, and taxonomic considerations. Braz J Biol (2005) 0.90
Thrombasthenia: immunologic evidence of a platelet protein abnormality. J Lab Clin Med (1966) 0.90
Studies with uraemic serum on the renal transport of hippurates and tetraethylammonium in the rabbit and rat: effects of oral neomycin. Clin Sci (1970) 0.90
Nature of the defect in congenital factor V deficiency: study in a patient with an acquired circulating anticoagulant. Blood (1972) 0.90
Correlation of immunologic and structural heterogeneity of Bence Jones proteins. J Immunol (1966) 0.89
Thrombotic thrombocytopenic purpura--coagulation parameters in twelve patients. Blood (1973) 0.89
The effect of platelet membrane antibodies on aggregation and release. Br J Haematol (1974) 0.89
Immunological studies of proteins associated with the subcellular fractions of thrombasthenic and afibrinogenaemic platelets. Br J Haematol (1968) 0.89
Multicultural medicine: fad or forgotten concept? CMAJ (1989) 0.88
Subtypes of Bence-Jones proteins. J Immunol (1965) 0.88
VH-gene family dominance in ageing mice. Scand J Immunol (1994) 0.88